Provider Focus Articles
Prior to penicillin, life expectancy was limited for patients with X-linked agammaglobulinemia. Thanks to the advent of intravenous immune globulin, the prognosis today is much more promising.
David T. Rubin MD, assistant professor of medicine at the University of Chicago Pritzker School of Medicine, is a leading authority on Crohn’s disease and ulcerative colitis.
Improved medications and lowered mortality rates have tasked providers with helping patients not only adhere to treatment plans, but also navigate the emotional and social implications of living long term with HIV.